Pure Global AI
NCT06362551Recruitment Completed

Oocyte Donor Application Discrepancies

Retrospective Analysis of Differences in Information Provided by Donor Applicants Obtained by Written Application Compared to Genetic Risk Assessment Performed by Certified Genetic Counselor as Part of Routine Screening Process
Inception Fertility, LLCClinicalTrials.gov
Verified
Study focus
Disease/Condition
Infertility
Study type
Observational
Sponsor & location
Primary sponsor
Inception Fertility, LLC
Location
Houston, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 25, 2024
End date
May 01, 2025
Enrollment
1000 participants
Primary outcome

Rate of additional information,Rate of applicant decline

Summary

Retrospective observational study comparing information received on Inception Central Donor
 Recruitment's standardized online egg donor application compared to information reported
 during a genetic risk assessment consultation with a certified genetic counselor with
 contracted third party genetic counseling service, GeneScreen. All donor applicants
 completing a full application with Inception's Central Donor Recruitment and a GRA
 consultation with GeneScreen will be included.

ICD-10 classifications
Female infertilityMale infertilityFemale infertility, unspecifiedFemale infertility of other originFemale infertility of uterine origin
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06362551
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06362551 through Pure Global AI's free database. This phase not specified trial is sponsored by Inception Fertility, LLC and is currently Recruitment Completed. The study focuses on Infertility. Target enrollment is 1000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.